American Healthcare REIT (NYSE:AHR) Stock Gets Price Target Trim from UBS Group

American Healthcare REIT (NYSE:AHR) had its price objective dropped by investment analysts at UBS Group from $63.00 to $62.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s target price would suggest a potential upside of 18.12% from the company’s current price.

A number of other brokerages also recently weighed in on AHR. Scotiabank raised their price objective on American Healthcare REIT from $56.00 to $62.00 and gave the company an “outperform” rating in a research note on Wednesday, September 2nd. Citigroup reissued a “market outperform” rating on shares of American Healthcare REIT in a research report on Monday, September 14th. Royal Bank Of Canada boosted their price objective on shares of American Healthcare REIT from $56.00 to $61.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Truist Financial boosted their price objective on shares of American Healthcare REIT from $57.00 to $61.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Finally, Compass Point assumed coverage on shares of American Healthcare REIT in a research note on Tuesday, July 21st. They issued a “buy” rating and a $70.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, American Healthcare REIT has a consensus rating of “Buy” and an average target price of $62.00.

American Healthcare REIT Stock Down 0.1%

American Healthcare REIT stock traded down $0.03 during mid-day trading on Tuesday, hitting $52.49. 2,901,825 shares of the company’s stock were exchanged, compared to its average volume of 2,979,811. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.24. The stock has a market cap of $11.44 billion, a P/E ratio of 77.19, a P/E/G ratio of 1.24 and a beta of 0.79. American Healthcare REIT has a 1-year low of $41.15 and a 1-year high of $58.70. The stock has a 50 day moving average of $53.67 and a two-hundred day moving average of $51.74.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. The company had revenue of $674.25 million during the quarter, compared to analysts’ expectations of $645.30 million. American Healthcare REIT had a return on equity of 3.63% and a net margin of 4.84%. The business’s quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.42 earnings per share. American Healthcare REIT has set its FY 2026 guidance at 2.150-2.190 EPS. As a group, analysts anticipate that American Healthcare REIT will post 2.18 EPS for the current fiscal year.

Insider Buying and Selling

In other American Healthcare REIT news, EVP Mark Foster sold 2,000 shares of American Healthcare REIT stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $55.39, for a total transaction of $110,780.00. Following the sale, the executive vice president owned 51,617 shares in the company, valued at $2,859,065.63. The trade was a 3.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.75% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On American Healthcare REIT

Hedge funds have recently made changes to their positions in the business. First Heartland Consultants Inc. lifted its holdings in shares of American Healthcare REIT by 4.0% during the 3rd quarter. First Heartland Consultants Inc. now owns 6,196 shares of the company’s stock worth $318,000 after acquiring an additional 241 shares during the period. GAMMA Investing LLC increased its stake in American Healthcare REIT by 42.0% in the third quarter. GAMMA Investing LLC now owns 4,635 shares of the company’s stock valued at $238,000 after acquiring an additional 1,371 shares during the period. CX Institutional increased its stake in American Healthcare REIT by 404.1% in the third quarter. CX Institutional now owns 17,927 shares of the company’s stock valued at $919,000 after acquiring an additional 14,371 shares during the period. Sequoia Financial Advisors LLC increased its stake in American Healthcare REIT by 5.0% in the second quarter. Sequoia Financial Advisors LLC now owns 18,702 shares of the company’s stock valued at $975,000 after acquiring an additional 899 shares during the period. Finally, WINTON GROUP Ltd acquired a new position in American Healthcare REIT in the second quarter worth about $1,377,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

American Healthcare REIT Company Profile

American Healthcare REIT, Inc (NYSE:AHR) is a real estate investment trust focused on owning and operating healthcare-related properties. The company seeks to provide real estate solutions for healthcare providers and operators while generating rental and operating income from a diversified portfolio.

Its portfolio includes outpatient medical properties, senior housing communities, skilled nursing facilities, hospitals and other healthcare assets. American Healthcare REIT also has exposure to healthcare operating businesses, including senior living and care services, through its relationship with Trilogy Health Services.